Navigation Links
Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
Date:1/10/2008

Biomarker discovery company builds strong financial and clinical foundation in preparation for release of technology enabling early detection of risk

for diabetes

EMERYVILLE, Calif., Jan. 10 /PRNewswire/ -- Tethys Bioscience today announced that it has reached two significant milestones in its drive to release Tethys Diabetes PreDxTM, a multi-biomarker technology that provides a more complete picture of an individual's future risk of developing diabetes. The company received its latest round of funding (Series C), and also received the licensing of its CLIA Lab by the State of California. Both moves place Tethys Bioscience in a strong position to establish itself as a leader in the emerging field of personalized predictive medicine and to achieve its goal of helping to stem the burgeoning epidemic of chronic, high-burden metabolic disease. Tethys Diabetes PreDxTM will be generally available in the first half of 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070702/AQM026LOGO)

The new round of funding is led by Intel Capital, which was created specifically to invest in innovation and has a strong interest in the emerging field of predictive personalized medicine. This latest financing, a process begun with earlier investments from some of the leading venture capital firms, including Kleiner Perkins Caufield & Byers and MDV-Mohr Davidow Ventures, results in a total of $54 million in financing, to date.

"We're very pleased to receive this round of financing from our investors, and believe it supports our vision to dramatically improve the detection and treatment, and ultimately prevention, of chronic diseases," said Mickey Urdea, CEO of Tethys Bioscience. "It gives us the resources to accelerate our work in this critical field, and to introduce a technology that enables a clinically simple blood test that provides an
'/>"/>

SOURCE MDV-Mohr Davidow Ventures
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
2. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
3. Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting
4. SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution
5. Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference
6. KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
9. YM BIOSCIENCES REPORTS FIRST QUARTER 2008 OPERATIONAL AND FINANCIAL RESULTS
10. Anaptys Biosciences Raises Over $33 Million in Series B Financing
11. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18, 2013 The Communities of ... special places we call home. These are the townships, villages ... are the locations where the people are friendly and neighbors ... viewers off the highways and shares the best in both ... nations with an American sports and film celebrity. It airs ...
(Date:5/18/2013)... TheBeautyPlace.com answers important questions about the hairloss ... a result of stress, nutrient deficiency or wearing a ... of men suffer from male patterned baldness. ... hair transplant surgery, but additionally carries a hair care ... Bosley Professional Strength. Their product line is a five-step ...
(Date:5/18/2013)... Although obesity is associated with an increased ... and esophageal adenocarcinoma, a type of esophageal cancer, is ... reported on Cancer.gov, last reviewed in January 2012, ... as those of normal and healthy weight to develop ... esophageal cancer is not well understood, it is now ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with ... are landing in emergency rooms across America. ... with a new treatment program for those addicted ... from the National Institute on Drug Abuse, synthetic marijuana ... teenagers. In 2012, 11 percent of high school seniors ...
(Date:5/18/2013)... 18, 2013 Rio Salon and Spa, ... a stylish renovation that features tranquil, Eastern Asian influenced ... the ground up, this Morro Bay day spa ... soothing colors and comfortable spa beds. Additional salon stations ... Apilus epilator machine. The shampoo area has been ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2
... Quantum Group,(Amex: QGP ) (http://www.QuantumMD.com ) ... become a third party administrator (TPA) with the ... company, Renaissance,Administrative Services, Inc. (RASI), to provide administrative ... A TPA provides an outsourced solution to ...
... low-sodium diet does not appear to have any appreciable ... new research. , "Despite the clear benefit of a ... therapeutic benefit in the use of a low-sodium dieton ... K. Pogson, M.R.C.P., clinical research fellow at the University ...
... Magnetic Resonance Imaging (MRI), and Broadlane’s clients awarded the High-Field Open ... ... Dallas, TX (PRWEB) July 15, 2008 -– Broadlane recently held ... Broadlane’s clients awarded the High-Field Open MRI contract to Hitachi Medical ...
... Obesity expert Sanford Siegal, D.O., M.D., known to generations as the ... 9th , ... McLean, VA (PRWEB) July 15, 2008 ... Dr. Siegal's® COOKIE DIET™ hunger-controlling foods and operator of seven ...
... full-day kindergarten have slightly better reading and math skills ... benefits diminish soon after the children leave kindergarten. This ... poverty and the quality of children,s home environments. , ... researchers at the University of Pittsburgh and Loyola University ...
... 14 Sun Pharmaceutical Industries,Ltd. (Reuters: SUN.BO, Bloomberg: ... its subsidiary, Alkaloida Chemical Company Exclusive Group,Ltd. (Alkaloida), ... Offer for,purchase of all outstanding Ordinary Shares of ... extended to 5:00 p.m., New York,City time, on ...
Cached Medicine News:Health News:The Quantum Group Files TPA Application 2Health News:The Quantum Group Files TPA Application 3Health News:Low-sodium advice for asthmatics should be taken with a grain of salt 2Health News:Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc. 2Health News:Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc. 3Health News:Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc. 4Health News:Eighth Dr. Siegal's COOKIE DIET Retail Location Opens August 1st at Tysons Corner Center Near Washington, DC 2Health News:Eighth Dr. Siegal's COOKIE DIET Retail Location Opens August 1st at Tysons Corner Center Near Washington, DC 3Health News:Full-day kindergarteners' reading, math gains fade by 3rd grade 2Health News:Sun Pharma Extends Tender Offer for Taro 2
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
(Date:5/16/2013)...  Today, the National Patient Advocate Foundation acknowledges that ... Representatives recently approved a bill that would prohibit insurers ... out-of-pocket fees for newer, more expensive oral anti-cancer drugs ... severe side-effects. However, the bill was amended to include ... to be a barrier to patients with cancer and ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... charge of their health at home through the merger of ... of $3.00 per share on its Series B Convertible Perpetual ... 15, 2013 to holders of record of Series B stock ... Such payment will cover the amount of all dividends ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... leading provider of prescription drug monitoring services and education to ... company,s founder and CEO James Slattery has been ... Entrepreneur Of The Year® 2011 Award for the San Diego ... 165 nominations by a panel of independent judges. The ...
... BEIJING, April 22, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: ... in China, announced today it has filed its Annual Report ... for the year ended December 31, 2010 on April 22, ... on www.sec.gov . The Company will provide ...
Cached Medicine Technology:Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 2Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 3Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 4Sinovac Files Annual Report on Form 20-F 2
2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
Straight iris forceps. Insulated....
Hardy bayonet forceps with stops. Insulated....
Cushing forceps. Insulated....
Medicine Products: